Dir
Timothy P. Sullivan is an independent Director at Option Care Health, Inc. (OPCH) since 2015, serving on the legacy Option Care board prior to its merger with BioScrip, and elevated to Vice Chair in 2024.[[1]](https://fintool.com/app/research/companies/OPCH/people/timothy-p-sullivan)[[4]](https://www.mdcp.com/team/timothy-p-sullivan) Aged 67, he recently engaged in insider trading, including a sale of 47,249 shares on August 22, 2024, valued at approximately $1.46 million, reducing his holdings to about 20,814 shares worth over $652,000, and a purchase of 20,000 shares on August 21, 2025, for $550,200.[[2]](https://www.gurufocus.com/insider/34599/timothy-p-sullivan)[[3]](https://www.nasdaq.com/articles/director-option-care-health-makes-146m-sale)[[6]](https://www.insiderscreener.com/en/company/option-care-health-inc) Sullivan owns around 49,229 shares as of recent reports.[[2]](https://www.gurufocus.com/insider/34599/timothy-p-sullivan)
Sullivan is Vice Chairman at Madison Dearborn Partners (MDP) since 2024, where he previously served as Co-CEO (2023–2024), Co-President (2022–2023), and Co-Founder/Managing Director/Co-Head of Health Care (1992–2022), leading healthcare investments.[[1]](https://fintool.com/app/research/companies/OPCH/people/timothy-p-sullivan)[[4]](https://www.mdcp.com/team/timothy-p-sullivan) His career highlights include prior roles at First Chicago Venture Capital and U.S. Navy service, alongside current board seats at APM, Kaufman Hall, Performance Health, and others in healthcare services.[[1]](https://fintool.com/app/research/companies/OPCH/people/timothy-p-sullivan)[[4]](https://www.mdcp.com/team/timothy-p-sullivan) He holds a B.S. from the United States Naval Academy, an M.S. from the University of Southern California, and an M.B.A. from Stanford Graduate School of Business.[[1]](https://fintool.com/app/research/companies/OPCH/people/timothy-p-sullivan)
View full insider profile →
